Company profile for HotSpot Therapeutics

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Inspired by nature’s ability to regulate protein function to restore health, HotSpot Therapeutics is discovering new allosteric therapies with the ability to treat disease in new ways. Unlike conventional drug discovery, which focuses on targeting the active sites of proteins, HotSpot has developed a technology platform to uncover nature’s privileged regulatory hotspots – pockets remote from the active site that are cri...
Inspired by nature’s ability to regulate protein function to restore health, HotSpot Therapeutics is discovering new allosteric therapies with the ability to treat disease in new ways. Unlike conventional drug discovery, which focuses on targeting the active sites of proteins, HotSpot has developed a technology platform to uncover nature’s privileged regulatory hotspots – pockets remote from the active site that are critical to protein function. Our team is designing novel therapies directed at regulatory hotspots, allowing us to treat diseases with limited or no known treatment options.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
50 Milk St, 16th floor Boston, MA 02109
Telephone
Telephone
+1 (617) 758-8998
youtube
YouTube

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

DDL Conference

Not Confirmed

envelop Contact Supplier

DDL Conference

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.prnewswire.com/news-releases/hotspot-therapeutics-presents-preclinical-data-from-small-molecule-cbm-signalosome-inhibitor-program-at-esmo-gastrointestinal-cancers-congress-2025-302496302.html

PR NEWSWIRE
04 Jul 2025

https://www.prnewswire.com/news-releases/hotspot-therapeutics-to-present-preclinical-data-from-small-molecule-cbm-signalosome-inhibitor-program-at-esmo-gastrointestinal-cancers-congress-2025-302491489.html

PR NEWSWIRE
26 Jun 2025

https://www.prnewswire.com/news-releases/hotspot-therapeutics-presents-preclinical-data-from-small-molecule-irf5-program-at-focis-2025-302491111.html

PR NEWSWIRE
25 Jun 2025

https://www.prnewswire.com/news-releases/hotspot-therapeutics-to-present-preclinical-data-from-small-molecule-irf5-program-at-focis-2025-302484574.html

PR NEWSWIRE
18 Jun 2025

https://www.prnewswire.com/news-releases/hotspot-therapeutics-presents-preclinical-data-from-malt1-cbm-signalosome-glue-program-at-36th-eortc-nci-aacr-symposium-302284027.html

PR NEWSWIRE
23 Oct 2024

https://www.prnewswire.com/news-releases/hotspot-therapeutics-appoints-alison-oneill-md-as-chief-medical-officer-302252482.html

PR NEWSWIRE
19 Sep 2024

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty